Skin Cancer News & Features
Melanoma screening strategies may be more feasible by focusing on high-risk populations.
A drug used to treat Lou Gehrig's disease has also been found to improve the effectiveness of radiation therapy when administered to laboratory models with melanoma that metastasized to the brain.
Researchers have uncovered how melanoma becomes resistant to a promising new drug combination utilizing BRAF+MEK inhibitors after an initial period of tumor shrinkage.
A recent, groundbreaking new study found that children of melanoma survivors are not adhering to sun protection recommendations.
The researchers have mapped the steps used by cells of melanoma, breast cancer, and the blood cancer myelofibrosis to become resistant to drugs, allowing for better success in blocking these pathways and further enabling therapies.
- Women educated on overdiagnsosis are less likely to want mammogram
- New treatment method shrinks ovarian cancer tumors and improves chemotherapy effectiveness
- Epigenetic signatures differentiate triple negative breast cancers
- Novel drug approved for multiple myeloma
- New mechanism of acquired resistance to breast cancer drugs discovered
- Patients with detectable PSA after prostatectomy should receive more aggressive radiation therapy
- Increase in brain tumors is not attributed to mobile phone use
- Black men have lower preference for investigation of prostate cancer
- ASCO: Active surveillance for prostate cancer may decrease survival odds for some
- Finding a qualified acupuncture practitioner
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|